Phospho-indoles as HIV inhibitors
US7534809B2 · kind B2 · utility
5Cited by
21References
82Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 16, 2005 |
| Grant date | May 19, 2009 |
| Priority date | — |
| Expiry date | Aug 26, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/5728
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
3-phosphoindole compounds for the treatment of retroviral infections, and particularly for HIV, are described. Also included are compositions comprising the 3-phosphoindole derivatives alone or in combination with one or more other anti-retroviral agents, processes for their preparation, and methods of manufacturing a medicament incorporating these compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.